BCL2 and cancer: As GSI1, MG132 induces G2/M arrest and apoptosis with loss of Bcl-2 expression (Yan et al, 2007), thus the therapeutic use of proteasome inhibitors are also being considered in cancer treatment (Voorhees et al, 2003; Sato et al, 2008).